Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma

Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma

Abstract Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Despite the proven efficacy of combined immunochemotherapy (R-CHOP) in the majority of patients, ~40% of DLBCL patients do not respond or will relapse and consequently have a very poor prognosis. The development of t...

Full description

Bibliographic Details
Main Authors: Myra Langendonk, Mathilde R. W. de Jong, Nienke Smit, Jonas Seiler, Bart Reitsma, Emanuele Ammatuna, Andor W. J. M. Glaudemans, Anke van den Berg, Gerwin A. Huls, Lydia Visser, Tom van Meerten
Format: Article
Language:English
Published: Nature Publishing Group 2022-03-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-022-00631-7

Internet

https://doi.org/10.1038/s41408-022-00631-7

Similar Items